These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management. Panzuto F, Massironi S, Partelli S, Campana D, Rinzivillo M, Invernizzi P, Andreasi V, Lamberti G, Falconi M. Surg Oncol; 2020 Dec; 35():141-148. PubMed ID: 32877883 [Abstract] [Full Text] [Related]
3. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M, Zhao P, Shi X, Zhao A, Zhang L, Zhou L. BMC Endocr Disord; 2017 Jul 13; 17(1):39. PubMed ID: 28705205 [Abstract] [Full Text] [Related]
4. Update in the management of gastroenteropancreatic neuroendocrine tumors. Sedlack AJH, Varghese DG, Naimian A, Yazdian Anari P, Bodei L, Hallet J, Riechelmann RP, Halfdanarson T, Capdevilla J, Del Rivero J. Cancer; 2024 Sep 15; 130(18):3090-3105. PubMed ID: 39012928 [Abstract] [Full Text] [Related]
5. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)]. Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology. Zhonghua Zhong Liu Za Zhi; 2022 Dec 23; 44(12):1305-1329. PubMed ID: 36575783 [Abstract] [Full Text] [Related]
6. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research]. Luley K, Gebauer J, Gebauer N, Tharun L, Buchmann I, Barkhausen J, von Bubnoff N, Lindner K, Keck T, Lehnert H, Schmid SM. Internist (Berl); 2020 Aug 23; 61(8):875-890. PubMed ID: 32676723 [Abstract] [Full Text] [Related]
8. How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery. Fermi F, Andreasi V, Muffatti F, Crippa S, Tamburrino D, Partelli S, Falconi M. Curr Oncol Rep; 2022 Feb 23; 24(2):227-239. PubMed ID: 35076884 [Abstract] [Full Text] [Related]
9. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study. Zhang X, Ma L, Bao H, Zhang J, Wang Z, Gong P. BMC Endocr Disord; 2014 Jul 08; 14():54. PubMed ID: 25001493 [Abstract] [Full Text] [Related]
10. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors. Cloyd JM, Konda B, Shah MH, Pawlik TM. Expert Rev Clin Pharmacol; 2019 Feb 08; 12(2):101-108. PubMed ID: 30582383 [Abstract] [Full Text] [Related]
11. Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years. Desai GS, Pande P, Chhabra V, Shah RC, Jagannath P. Indian J Gastroenterol; 2019 Oct 08; 38(5):399-410. PubMed ID: 31802438 [Abstract] [Full Text] [Related]
12. Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) - Current literature review of diagnostics and therapy. What has changed in the management? Jurkiewicz K, Miciak M, Kaliszewski K. Pol Przegl Chir; 2024 Mar 08; 96(4):58-66. PubMed ID: 39138986 [Abstract] [Full Text] [Related]
13. Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions. Deroose CM, Hindié E, Kebebew E, Goichot B, Pacak K, Taïeb D, Imperiale A. J Nucl Med; 2016 Dec 08; 57(12):1949-1956. PubMed ID: 27811124 [Abstract] [Full Text] [Related]
17. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors]. Chen H, Chen Y. Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep 25; 20(9):982-986. PubMed ID: 28900987 [Abstract] [Full Text] [Related]